|
Match
|
Document |
Document Title |
|
|
8962018 |
Oral formulation of anhydrous olanzapine form I
The invention relates to a solid formulation for the oral administration of olanzapine that comprises a core of anhydrous olanzapine Form I or a pharmaceutically acceptable salt thereof and,... |
|
|
8956654 |
Sustained release dosage form
An osmotic dosage form which comprising: (a) a core comprising a biologically active ingredient;(b) a semi-permeable membrane covering said core; and(c) at least one passageway through the... |
|
|
8951558 |
Aqueous carbonated medium containing an amino(meth)acrylate polymer or copolymer
The invention relates to an aqueous medium containing an amino(meth)acrylate polymer or copolymer which is not soluble in dematerialised water, characterized in that the medium has a content of an... |
|
|
8945622 |
Sustained release composition of therapeutic agent
A pH dependent drug delivery system comprising a pH sensitive graft copolymer, a therapeutically active agent and other pharmaceutically acceptable ingredients. More specifically, a composition... |
|
|
8933081 |
Melting tablet containing a sildenafil salt
The invention relates to an orodispersible tablet comprising the components pharmaceutically acceptable sildenafil salt (a), polymeric adsorbent (b), in particular cation exchanger resin,... |
|
|
8920840 |
Enteric tablet
The present invention relates to an enteric tablet with improved bioavailability, which is rapidly disintegrated after reaching the intestine to allow dissolution of the active ingredient, and... |
|
|
8900575 |
Compositions and methods for oxalate reduction
The present invention comprises methods and compositions for the reduction of oxalate in humans. For example, the invention provides methods and compositions for the delivery of one or more... |
|
|
8895064 |
Controlled release and taste masking oral pharmaceutical composition
Controlled release and taste masking compositions containing one or more active principles inglobated in a three-component matrix structure, i.e. a structure formed by successive amphiphilic,... |
|
|
8858991 |
Delayed release oral pharmaceutical dosage forms comprising MGBG
Disclosed herein are controlled-release oral pharmaceutical dosage forms comprising MGBG, and their application for the improved treatment of diseases with reduced side effects and/or longer time... |
|
|
8815293 |
Organic compounds
A depot formulation comprising iloperidone and a biodegradable, biocompatible polymer. Preferably, the polymer is a star polymer. |
|
|
8790693 |
Aqueous polymer dispersion based on N,N-diethylaminoethyl methacrylate, its preparation and use
The present invention relates to a process for preparing an aqueous polymer dispersion by free-radical emulsion polymerization of a monomer mixture which comprises N,N-diethylaminoethyl... |
|
|
8772292 |
Process for the preparation of a medicament comprising vardenafil hydrochloride trihydrate
The present invention relates to a process for the preparation of a medicament containing vardenafil hydrochloride trihydrate in solid form, in which vardenafil hydrochloride trihydrate is... |
|
|
8771739 |
Pharmaceutical compositions for poorly soluble drugs
The present invention provides a pharmaceutical composition of a practically insoluble drug, wherein the composition may be administered with food or without food. The composition may be in the... |
|
|
8722650 |
Extended-release minocycline dosage forms
An oral dosage form has the following: an amount of minocycline selected from the group consisting of 55 mg, 80 mg, and 105 mg; an amount of lactose monohydrate; an amount of... |
|
|
8715730 |
Therapeutic or prophylactic agent for dyskinesia
The present invention relates to a stable orally disintegrating coated tablet containing a drug, wherein the tablet is coated with a coating layer containing a water-soluble substance and a... |
|
|
8715729 |
Rapidly disintegrating, solid coated dosage form
Rapidly disintegrating, solid coated dosage form comprising a solid core consisting of at least 60% by weight of an auxiliary mixture, up to 40% by weight of at least one active ingredient, and... |
|
|
8658208 |
Coated solid preparation
A montelukast-containing coated solid preparation can be applied to one-dose package, wherein the humidity stability of montelukast or a pharmacologically acceptable salt thereof contained therein... |
|
|
8652521 |
Coated solid preparation
A coated solid preparation includes an active ingredient including valproic acid or a pharmacologically acceptable salt thereof, and a coating layer containing polyvinyl alcohol and swelling clay... |
|
|
8647645 |
Enhanced moisture barrier immediate release film coating systems and substrates coated therewith
The present invention is directed to immediate release film coating systems for use on oral dosage forms such as compressed tablets and other orally-ingestible substrates which have improved... |
|
|
8632808 |
Taste-masking solid preparation of pioglitazone
A solid preparation sufficiently masking the unpleasant taste of pioglitazone or a salt thereof; a solid preparation sufficiently masking the unpleasant taste of pioglitazone or a salt thereof and... |
|
|
8628799 |
Coated tablet formulation and method
A coated tablet formulation is provided which includes a medicament such as the DPP4-inhibitor, saxaglipitin which is subject to intra-molecular cyclization, which formulation includes a tablet... |
|
|
8609198 |
Pharmaceutical dose form with a patterned coating and method of making the same
A method for producing a pharmaceutical dose form includes depositing a measured quantity of a first coating material on an external surface of the dose form in a patterned configuration. A... |
|
|
8557285 |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
The present invention is directed to drug dosage forms that release an agent that raises the pH of a patient's gastrointestinal tract, followed by a non-steroidal anti-inflammatory drug. The... |
|
|
8552102 |
Coating composition
The present invention relates to a novel resin composition useful as a coating agent or a binder for medicines, drugs for animals, agricultural chemicals, fertilizers, foods or the like, which... |
|
|
8524277 |
Extended release dosage form
A membrane system comprising an interior wall, a fluid-permeable exterior wall surrounding the interior wall and an internal compartment defined by the membrane system, wherein fluid permeability... |
|
|
8491929 |
Bioadhesive polymers
Polymers and compositions, collectively “bioadhesive materials”, with improved bioadhesive properties have been developed. One or more compounds comprising: a) an aromatic moiety comprising two or... |
|
|
8486429 |
Storage stable formulation and a process for its preparation
The present invention is directed to a storage stable insecticidal composition comprising one or more Chloronicotynyle compound, in an amount ranging from 0.1 to 5% by weight of the composition,... |
|
|
8465777 |
Diffusion-controlled dosage form and method of fabrication including three dimensional printing
The invention includes a core-and-shell dosage form or unit in which the core contains API and in which the shell substantially governs the release such as by controlling diffusion of API through... |
|
|
8399016 |
Sustained-release tablet composition of pramipexole
A sustained-release pharmaceutical composition in a form of an orally deliverable tablet comprises a water-soluble salt of pramipexole, dispersed in a matrix comprising a hydrophilic polymer and a... |
|
|
8329216 |
Oxymorphone controlled release formulations
The invention pertains to a method of relieving pain by administering a controlled release pharmaceutical tablet containing oxymorphone which produces a mean minimum blood plasma level 12 to 24... |
|
|
8309122 |
Oxymorphone controlled release formulations
The invention pertains to a method of relieving pain by administering a controlled release pharmaceutical tablet containing oxymorphone which produces a mean minimum blood plasma level 12 to 24... |
|
|
8277844 |
Coating composition
The present invention relates to a novel resin composition useful as a coating agent or a binder for medicines, drugs for animals, agricultural chemicals, fertilizers, foods or the like, which... |
|
|
8277840 |
Sustained release formulation of alprazolam
The present invention is directed towards the preparation of extended release Alprazolam formulation. The formulation thus obtained provides an efficient mode of delivery of Alprazolam in a... |
|
|
8268333 |
Orally administered agent and an orally administered agent/supporting substrate complex
With an object of providing an orally administered agent (in particular a film-shaped orally administered agent) with which the ease and safety of taking the agent are improved, to attain this... |
|
|
8268804 |
Minocycline oral dosage forms for the treatment of acne
Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne. |
|
|
8252776 |
Minocycline oral dosage forms for the treatment of acne
Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne. |
|
|
8206741 |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
The present invention is directed to drug dosage forms that release an agent that raises the pH of a patient's gastrointestinal tract, followed by a non-steroidal anti-inflammatory drug. The... |
|
|
8147871 |
Pharmaceutical formulations
The present invention is directed to novel pharmaceutically acceptable polymeric compositions suitable for melt extrusion and injection molding of single or multi-component pharmaceutical dosage... |
|
|
8137734 |
Preparation of controlled release skeletal muscle relaxant dosage forms
The present invention is directed to a method of preparing an extended release pharmaceutical composition comprising cyclobenzaprine, comprising coating inert particles with a... |
|
|
8088415 |
Diffusion-controlled dosage form and method of fabrication including three dimensional printing
The invention includes a core-and-shell dosage form or unit in which the core contains API and in which the shell substantially governs the release such as by controlling diffusion of API through... |
|
|
8017032 |
Tablet composition for the in-situ generation of chlorine dioxide for use in antimicrobial applications
A solid composition in the form of a tablet that generates and releases a biocidal solution comprising at least chlorine dioxide with an enhanced weight percent yield is presented. The composition... |
|
|
7993545 |
Tablet composition for the in-situ generation of chlorine dioxide for use in antimicrobial applications
A solid composition in the form of a tablet that generates and releases a biocidal solution comprising at least chlorine dioxide with an enhanced weight percent yield is presented. The composition... |
|
|
7985427 |
Gastric juice-resistant device for releasing mucoadhesive active substance excipients, and method for producing this gastric juice-resistant device
The invention relates to a gastric juice-resistant device for releasing active substance excipients having delayed intestinal passage from a gastric juice-resistant enclosure, and which serves to... |
|
|
7964215 |
Delayed release dosage form
The present invention is directed to a delayed release pharmaceutical composition in solid dosage form comprising a core comprised of a therapeutically effective amount of drug, e.g., mesalamine,... |
|
|
7959947 |
Film coating
A film coating composition suitable for use in coating pharmaceutical formulations comprising a) an acrylic polymer dispersion, e.g. an ethylacrylate/methylmethacrylate copolymer such as Eudragit... |
|
|
7919483 |
Method for the treatment of acne
A method for treatment of acne with tetracyclines is provided. A lower sustained dose and no loading dose is employed, with an optional once-a-day dosing regimen. |
|
|
7790705 |
Minocycline oral dosage forms for the treatment of acne
Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne. |
|
|
7780987 |
Controlled release dosage forms
The invention provides stable controlled release monolithic coating compositions for use in coating pharmaceutical oral dosage forms comprising a polyglycol having a melting point greater than 55°... |
|
|
7776358 |
Extended release venlafaxine besylate tablets
Venlafaxine besylate is formulated into an extended release tablet in high loading rates by use of a coating that contains ammonio methacrylate copolymer(s). |
|
|
7767230 |
Organic compounds
A depot formulation comprising iloperidone and a biodegradable, biocompatible polymer. Preferably, the polymer is a star polymer. |